SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-086988
Filing Date
2021-06-29
Accepted
2021-06-29 19:10:25
Documents
1
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120992d2_4.html 4  
1 OWNERSHIP DOCUMENT tm2120992d2_4.xml 4 3714
  Complete submission text file 0001104659-21-086988.txt   5083
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Issuer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 256 SUMMIT AVE BROOKLINE MA 02446
Business Address
Freeman Roy Lester (Reporting) CIK: 0001799732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39676 | Film No.: 211059680